BioCryst Pharmaceuticals (BCRX) Short Interest Ratio & Short Volume

$7.98

-0.15 (-1.85%)

(As of 09/6/2024 ET)

BioCryst Pharmaceuticals Short Interest Data

BioCryst Pharmaceuticals (BCRX) has a short interest of 24.81 million shares. This marks a 1.76% increase in short interest from the previous month. The short interest ratio (days to cover) is 8.2, indicating that it would take 8.2 days of the average trading volume of 3.23 million shares to cover all short positions.

Current Short Interest: 24,810,000 shares
Previous Short Interest: 24,380,000 shares
Change Vs. Previous Month: +1.76%
Dollar Volume Sold Short: $189.30 million
Short Interest Ratio: 8.2 Days to Cover
Last Record Date: August 15, 2024

Outstanding Shares: 206,377,000 shares
Percentage of Shares Shorted: 12.02%
Today's Trading Volume: 1,287,010 shares
Average Trading Volume: 3,226,499 shares
Today's Volume Vs. Average: 40%

Short Selling BioCryst Pharmaceuticals?

cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for BioCryst Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Short Interest Chart Days to Cover Chart Short Percent of Float Chart

BCRX Short Interest Over Time

BCRX Days to Cover Over Time

BCRX Percentage of Float Shorted Over Time

Ad Deal Maker

The solution to fast food’s wage hike crisis

Shake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.

Learn more about this much-needed advancement and investment opportunity here.

BioCryst Pharmaceuticals Short Interest History

Export to Excel

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Days to Cover	Price on Report Date
8/15/2024	24,810,000 shares	$189.30 million	+1.8%	N/A	8.2	$7.63
7/31/2024	24,380,000 shares	$177.49 million	+11.8%	N/A	7.1	$7.28
7/15/2024	21,810,000 shares	$156.60 million	+22.0%	N/A	6	$7.18
6/30/2024	17,880,000 shares	$110.50 million	-39.7%	N/A	5	$6.18
6/15/2024	29,670,000 shares	$183.06 million	-18.0%	N/A	8.1	$6.17
5/31/2024	36,180,000 shares	$233.72 million	+5.3%	N/A	9.9	$6.46
Get the Latest News and Ratings for BCRX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for BioCryst Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
5/15/2024	34,350,000 shares	$218.47 million	+2.1%	N/A	9.5	$6.36
4/30/2024	33,640,000 shares	$138.93 million	-2.2%	N/A	9.9	$4.13
4/15/2024	34,390,000 shares	$160.60 million	+6.6%	N/A	11	$4.67
3/31/2024	32,250,000 shares	$163.83 million	+5.6%	N/A	9.8	$5.08
3/15/2024	30,550,000 shares	$152.75 million	+5.0%	N/A	9.3	$5.00
2/29/2024	29,100,000 shares	$163.83 million	-1.1%	N/A	7.4	$5.63
2/15/2024	29,410,000 shares	$165.87 million	+1.3%	N/A	7.6	$5.64
1/31/2024	29,040,000 shares	$153.91 million	+3.5%	N/A	7.6	$5.30
1/15/2024	28,050,000 shares	$178.12 million	-6.8%	N/A	7.1	$6.35
12/31/2023	30,080,000 shares	$180.18 million	+1.0%	N/A	7.4	$5.99
12/15/2023	29,780,000 shares	$184.34 million	+1.4%	N/A	7.8	$6.19
11/30/2023	29,380,000 shares	$172.75 million	-0.3%	N/A	8.5	$5.88
11/15/2023	29,470,000 shares	$153.54 million	-2.2%	N/A	10.3	$5.21
10/31/2023	30,130,000 shares	$165.41 million	-31.8%	N/A	10.9	$5.49
10/15/2023	44,190,000 shares	$262.49 million	+4.3%	N/A	15.5	$5.94
9/30/2023	42,390,000 shares	$300.12 million	-0.3%	N/A	17	$7.08
9/15/2023	42,500,000 shares	$291.13 million	+2.9%	N/A	16.9	$6.85
8/31/2023	41,300,000 shares	$293.64 million	+3.1%	N/A	16.3	$7.11
8/15/2023	40,060,000 shares	$278.02 million	+2.7%	N/A	15.2	$6.94
7/31/2023	39,000,000 shares	$288.21 million	+3.4%	N/A	14.7	$7.39
7/15/2023	37,730,000 shares	$269.01 million	+0.9%	N/A	14.9	$7.13
6/30/2023	37,390,000 shares	$263.23 million	+5.4%	N/A	13.8	$7.04
6/15/2023	35,480,000 shares	$283.13 million	-0.3%	N/A	12.9	$7.98
5/31/2023	35,580,000 shares	$294.25 million	+10.2%	N/A	13	$8.27
5/15/2023	32,300,000 shares	$283.27 million	+3.5%	N/A	11	$8.77
4/30/2023	31,200,000 shares	$237.43 million	+2.8%	N/A	10.2	$7.61
4/15/2023	30,360,000 shares	$245.01 million	-2.8%	N/A	10.5	$8.07
3/31/2023	31,220,000 shares	$260.37 million	+1.3%	N/A	10.7	$8.34
3/15/2023	30,810,000 shares	$257.88 million	+4.5%	N/A	10.3	$8.37
2/28/2023	29,480,000 shares	$260.90 million	+9.2%	N/A	9.9	$8.85
2/15/2023	26,990,000 shares	$274.22 million	+1.2%	N/A	9.7	$10.16
1/31/2023	26,680,000 shares	$281.47 million	+2.2%	N/A	10.2	$10.55
1/15/2023	26,110,000 shares	$265.28 million	-4.2%	N/A	8.8	$10.16
12/30/2022	27,240,000 shares	$312.72 million	-1.6%	N/A	9.6	$11.48
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late.
12/15/2022	27,680,000 shares	$299.22 million	+0.3%	N/A	10.3	$10.81
11/30/2022	27,610,000 shares	$368.87 million	-0.9%	N/A	10.3	$13.36
11/15/2022	27,870,000 shares	$369.00 million	+0.9%	N/A	10.7	$13.24
10/31/2022	27,630,000 shares	$368.86 million	-2.3%	N/A	10.5	$13.35
10/15/2022	28,290,000 shares	$382.76 million	+0.6%	N/A	11	$13.53
9/30/2022	28,130,000 shares	$354.44 million	-2.4%	N/A	10.9	$12.60
9/15/2022	28,820,000 shares	$369.76 million	+3.3%	N/A	10.5	$12.83
8/31/2022	27,910,000 shares	$387.95 million	+2.1%	N/A	9.7	$13.90
8/15/2022	27,350,000 shares	$405.05 million	-7.9%	N/A	9.1	$14.81
7/31/2022	29,680,000 shares	$327.07 million	-5.7%	N/A	8.7	$11.02
7/15/2022	31,460,000 shares	$366.51 million	+0.5%	N/A	8.5	$11.65
6/30/2022	31,300,000 shares	$331.15 million	+5.4%	N/A	6.4	$10.58
6/15/2022	29,690,000 shares	$276.12 million	+0.5%	N/A	6.2	$9.30
5/31/2022	29,550,000 shares	$275.11 million	-0.3%	N/A	6.3	$9.31
5/15/2022	29,650,000 shares	$248.76 million	-3.4%	N/A	6.1	$8.39
4/30/2022	30,690,000 shares	$285.11 million	+7.5%	N/A	6.4	$9.29
4/15/2022	28,550,000 shares	$325.18 million	+11.7%	N/A	6.5	$11.39
3/31/2022	25,570,000 shares	$415.77 million	-5.4%	N/A	5.6	$16.26
3/15/2022	27,030,000 shares	$409.77 million	+2.0%	N/A	6.9	$15.16
2/28/2022	26,500,000 shares	$440.17 million	+2.6%	N/A	7	$16.61
2/15/2022	25,820,000 shares	$484.38 million	+3.2%	14.7%	6.9	$18.76
1/31/2022	25,020,000 shares	$386.56 million	-1.8%	14.1%	7.1	$15.45
1/15/2022	25,470,000 shares	$394.28 million	-2.3%	14.4%	7	$15.48
12/31/2021	26,080,000 shares	$361.21 million	+6.3%	14.8%	8	$13.85
12/15/2021	24,540,000 shares	$291.29 million	+1.5%	14.0%	8.7	$11.87
11/30/2021	24,180,000 shares	$291.61 million	+7.2%	13.7%	8.9	$12.06
11/15/2021	22,550,000 shares	$267.67 million	+10.4%	12.7%	8.6	$11.87
10/29/2021	20,420,000 shares	$304.87 million	+7.6%	11.5%	7.4	$14.93
10/15/2021	18,970,000 shares	$287.02 million	+2.3%	10.7%	7.2	$15.13
9/30/2021	18,540,000 shares	$266.42 million	-2.3%	10.5%	6.9	$14.37
9/15/2021	18,980,000 shares	$286.03 million	-1.6%	10.7%	6.8	$15.07
8/31/2021	19,290,000 shares	$307.10 million	-6.1%	10.9%	6.5	$15.92
8/13/2021	20,540,000 shares	$331.72 million	+11.9%	11.6%	6.4	$16.15
7/30/2021	18,350,000 shares	$295.80 million	-0.1%	10.5%	5.4	$16.12
7/15/2021	18,370,000 shares	$290.25 million	-4.1%	10.5%	5.3	$15.80
6/30/2021	19,150,000 shares	$302.76 million	-2.0%	10.9%	5.2	$15.81
6/15/2021	19,530,000 shares	$304.86 million	-2.4%	11.1%	5.1	$15.61
5/28/2021	20,010,000 shares	$315.56 million	-9.6%	11.4%	4.3	$15.77
5/14/2021	22,130,000 shares	$264.67 million	-3.6%	N/A	4.3	$11.96
4/30/2021	22,950,000 shares	$278.15 million	-8.1%	N/A	4.1	$12.12
4/15/2021	24,980,000 shares	$254.55 million	+7.0%	N/A	3.7	$10.19
3/31/2021	23,350,000 shares	$233.27 million	-12.5%	N/A	3.3	$9.99
3/15/2021	26,680,000 shares	$337.24 million	-7.8%	N/A	3.5	$12.64
2/26/2021	28,920,000 shares	$302.79 million	+0.2%	N/A	3.5	$10.47
2/12/2021	28,860,000 shares	$265.51 million	-8.5%	N/A	3.5	$9.20
1/29/2021	31,530,000 shares	$274.63 million	+1.9%	N/A	4	$8.71
1/15/2021	30,950,000 shares	$265.86 million	No Change	N/A	4.6	$8.59
12/31/2020	30,950,000 shares	$232.13 million	-16.4%	N/A	4.7	$7.50
12/15/2020	37,040,000 shares	$314.84 million	-1.0%	N/A	5.5	$8.50
11/30/2020	37,420,000 shares	$191.96 million	-1.7%	N/A	6.2	$5.13
“Fed Proof” Your Bank Account with THESE 4 Simple Steps (Ad) Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account. Learn these 4 simple steps and protect your savings before it’s too late.
11/15/2020	38,070,000 shares	$167.89 million	-7.9%	N/A	7.6	$4.41
10/30/2020	41,320,000 shares	$154.12 million	+8.5%	N/A	8.1	$3.73
10/15/2020	38,100,000 shares	$147.83 million	+4.7%	N/A	6.8	$3.88
9/30/2020	36,390,000 shares	$125.00 million	+5.0%	N/A	6.2	$3.44
9/15/2020	34,650,000 shares	$138.60 million	+3.3%	N/A	5.3	$4.00
8/31/2020	33,560,000 shares	$139.27 million	-11.7%	N/A	4.8	$4.15
8/14/2020	38,010,000 shares	$163.44 million	+11.8%	N/A	5.2	$4.30
7/31/2020	34,000,000 shares	$138.38 million	+9.3%	N/A	4.1	$4.07
7/15/2020	31,100,000 shares	$162.50 million	-3.1%	N/A	3.2	$5.23
6/30/2020	32,100,000 shares	$152.96 million	+55.6%	N/A	2.9	$4.77
6/15/2020	20,630,000 shares	$92.63 million	+11.9%	N/A	2	$4.49
5/29/2020	18,430,000 shares	$82.75 million	+8.0%	N/A	1.7	$4.49
5/15/2020	17,070,000 shares	$90.30 million	-4.6%	N/A	1.6	$5.29
4/30/2020	17,890,000 shares	$69.95 million	+1.5%	N/A	1.9	$3.91
4/15/2020	17,630,000 shares	$47.60 million	+11.2%	N/A	2.3	$2.70
3/31/2020	15,860,000 shares	$56.46 million	-1.2%	N/A	2.8	$3.56
3/13/2020	16,053,900 shares	$33.23 million	+7.5%	N/A	1.6	$2.07
2/28/2020	14,940,000 shares	$29.28 million	-2.3%	N/A	3.3	$1.96
2/14/2020	15,290,000 shares	$42.96 million	-4.7%	N/A	4.5	$2.81
1/31/2020	16,050,000 shares	$40.61 million	-0.6%	N/A	4.3	$2.53
1/15/2020	16,140,000 shares	$46.81 million	-10.3%	N/A	4.6	$2.90
12/31/2019	18,000,000 shares	$50.58 million	+31.4%	N/A	6.4	$2.81
11/15/2019	15,750,000 shares	$40.01 million	+13.0%	14.5%	10.9	$2.54

BCRX Short Interest - Frequently Asked Questions

What is BioCryst Pharmaceuticals' current short interest?: Short interest is the volume of BioCryst Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of August 15th, traders have sold 24,810,000 shares of BCRX short. Learn More on BioCryst Pharmaceuticals' current short interest.
What is a good short interest ratio for BioCryst Pharmaceuticals?: The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCRX shares currently have a short interest ratio of 8.0. Learn More on BioCryst Pharmaceuticals's short interest ratio.
Is BioCryst Pharmaceuticals' short interest increasing or decreasing?: BioCryst Pharmaceuticals saw a increase in short interest in August. As of August 15th, there was short interest totaling 24,810,000 shares, an increase of 1.8% from the previous total of 24,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
How does BioCryst Pharmaceuticals' short interest compare to its competitors?: Here is how the short interest of companies in the sector of "medical" compare to BioCryst Pharmaceuticals: Aligos Therapeutics, Inc. (0.57%), Taysha Gene Therapies, Inc. (10.14%), Adaptimmune Therapeutics plc (2.89%), Vaxart, Inc. (7.65%), Passage Bio, Inc. (3.67%), Krystal Biotech, Inc. (12.40%), Ionis Pharmaceuticals, Inc. (7.39%), Madrigal Pharmaceuticals, Inc. (17.27%), Alkermes plc (10.46%), Amicus Therapeutics, Inc. (8.12%),

Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.23 billion), Aptiv PLC ($2.50 billion), Royal Caribbean Cruises Ltd. ($2.48 billion), Paychex, Inc. ($2.25 billion), Moderna, Inc. ($2.17 billion), Cencora, Inc. ($2.12 billion), Tractor Supply ($1.93 billion), Onsemi ($1.82 billion), International Paper ($1.81 billion), and Rivian Automotive, Inc. ($1.72 billion). View all of the most shorted stocks.
What does it mean to sell short BioCryst Pharmaceuticals stock?: Short selling BCRX is an investing strategy that aims to generate trading profit from BioCryst Pharmaceuticals as its price is falling. BCRX shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against BioCryst Pharmaceuticals?: A short squeeze for BioCryst Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BCRX, which in turn drives the price of the stock up even further.
How often is BioCryst Pharmaceuticals' short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCRX, twice per month. The most recent reporting period available is August, 15 2024.